tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ARWR Stock Latest News

B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
The FlyB. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
10d ago
ALT
PFE
Arrowhead price target lowered to $60 from $90 at H.C. Wainwright
PremiumThe Fly
Arrowhead price target lowered to $60 from $90 at H.C. Wainwright
17d ago
ARWR
Arrowhead to advance plozasiran into Phase 3 cardiovascular outcomes trial
PremiumThe Fly
Arrowhead to advance plozasiran into Phase 3 cardiovascular outcomes trial
27d ago
ARWR
Arrowhead presents preclinical data on new ARO-INHBE
PremiumThe Fly
Arrowhead presents preclinical data on new ARO-INHBE
28d ago
ARWR
Ionis Pharmaceuticals upgraded to Market Perform from Underperform at Bernstein
PremiumThe Fly
Ionis Pharmaceuticals upgraded to Market Perform from Underperform at Bernstein
1M ago
ALNY
ARWR
Instacart, Boston Beer upgraded: Wall Street’s top analyst calls
PremiumThe FlyInstacart, Boston Beer upgraded: Wall Street’s top analyst calls
2M ago
HY
COP
Arrowhead initiated with a Neutral at Goldman Sachs
PremiumThe Fly
Arrowhead initiated with a Neutral at Goldman Sachs
2M ago
ARWR
Arrowhead announces topline results from PALISADE study
PremiumThe Fly
Arrowhead announces topline results from PALISADE study
2M ago
ARWR
Arrowhead announces results from ARCHES-2 study
PremiumThe Fly
Arrowhead announces results from ARCHES-2 study
2M ago
ARWR
Arrowhead presents new Phase 2 Data of plozasiran in hyperlipidemia
PremiumThe Fly
Arrowhead presents new Phase 2 Data of plozasiran in hyperlipidemia
2M ago
ARWR
Arrowhead announces new interim clinical data on ARO-RAGE
PremiumThe Fly
Arrowhead announces new interim clinical data on ARO-RAGE
2M ago
ARWR
Arrowhead price target lowered to $27 from $36 at Morgan Stanley
PremiumThe Fly
Arrowhead price target lowered to $27 from $36 at Morgan Stanley
2M ago
ARWR
Arrowhead price target lowered to $29 from $34 at Citi
PremiumThe FlyArrowhead price target lowered to $29 from $34 at Citi
2M ago
ARWR
Arrowhead reports Q2 EPS ($1.02), consensus (16c)
PremiumThe Fly
Arrowhead reports Q2 EPS ($1.02), consensus (16c)
2M ago
ARWR
ARWR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ARWR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ARWR
Arrowhead earns $50M milestone from Royalty Pharma
PremiumThe Fly
Arrowhead earns $50M milestone from Royalty Pharma
3M ago
AMGN
ARWR
Biotech Sector: M&A Fuels Renewed Excitement
PremiumMarket News
Biotech Sector: M&A Fuels Renewed Excitement
3M ago
NVS
XBI
Arrowhead begins Phase 1/2a study of ARO-CFB for mediated kidney disease
PremiumThe Fly
Arrowhead begins Phase 1/2a study of ARO-CFB for mediated kidney disease
3M ago
ARWR
Athira Pharma appoints Javier San Martin as Chief Medical Officer
PremiumThe Fly
Athira Pharma appoints Javier San Martin as Chief Medical Officer
3M ago
ARWR
ATHA
Arrowhead announces new Phase 2 SHASTA-2 study of plozasiran in SHTG
PremiumThe FlyArrowhead announces new Phase 2 SHASTA-2 study of plozasiran in SHTG
4M ago
ARWR
Arrowhead begins EAP to avail plozasiran outside of trials for patients with FCS
PremiumThe Fly
Arrowhead begins EAP to avail plozasiran outside of trials for patients with FCS
4M ago
ARWR
Arrowhead CFO Myszkowski sells 40,000 common shares
PremiumThe Fly
Arrowhead CFO Myszkowski sells 40,000 common shares
5M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >